Know Labs Inc (KNW)

[Know Labs]

Know Labs Invents New Way to Detect Blood Glucose Non Invasively

Seattle, WA. – July 10, 2018 – Know Labs, Inc. (f/k/a Visualant, Incorporated) (OTCQB: KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video Company’s invention of a new technology to detect blood glucose non-invasively. In the video Company CEO Phil Bosua briefly discusses the breakthrough.

The transcript of Phil Bosua’s narrative in the video states in part:

“We’re developing a brand-new technology platform that measures blood glucose - non-invasively. Our bench tests are proving to be better than expected and we’re really excited about the future.”

Link to video:

More information: http://www.knowlabs.co/

About Know Labs, Inc.

Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose shares currently trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. The Company refers to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio-RFID are used to identify, detect, or diagnose substance markers or biomarkers that may be invisible to the human eye. ChromaID and Bio-RFID scanner modules can be integrated into a variety of wearable, mobile or bench-top form factors. This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or large and expensive lab-based tests.